Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Satoshi Akahane"'
Autor:
Masayuki Isaji, Akane Matsuzawa, Masuo Akahane, Toshiki Homma, Fumiki Oana, Hiroo Takeda, Satoshi Akahane
Publikováno v:
Pharmacological Research. 52:395-400
We aimed to examine the effects of KTO-7924 (β3-adrenoceptor agonist) on lipid metabolism and mRNA expressions in retroperitoneal white adipose tissue (RP WAT) in obese (fa/fa) Zucker rats using DNA microarray. Oral KTO-7924 for 28 days significantl
Publikováno v:
European Journal of Pharmacology. 518:71-76
Our aim was to determine the effect of a β3-adrenoceptor agonist on plasma adiponectin levels and on the level of expression of mRNA for adiponectin, adiponectin receptor 1, and adiponectin receptor 2 in db/db mice. Two weeks' oral administration of
Autor:
Hiroshi Miyata, Masuo Akahane, Yoshinobu Yamazaki, Osamu Nishizawa, Masami Kojima, Yasuhiko Igawa, Hiroo Takeda, Kouich Kaidoh, Satoshi Akahane, Akane Matsuzawa
Publikováno v:
Journal of Urology. 170:654-658
We compared the effect of a beta 3-adrenoceptor (AR) agonist with that of beta 1 and beta 2-AR agonists on the urethra and bladder in the dog and rat.In an in vitro experiment we studied the relaxant effect of subtype selective beta-AR agonists in ca
Autor:
Kiyoto Hara, Masami Kojima, Satoshi Akahane, Takashi Koizumi, Toshiki Honma, Yuji Hoyano, Masahiko Uchida, Masuo Akahane
Publikováno v:
Journal of Health Science. 49:368-378
A Cynomolgus monkey hemodialysis model was used to evaluate the efficacy of a new factor Xa (FXa) inhibitor as an anticoagulant for hemodialysis. We tested the selective FXa inhibitor KFA-1411, using doses of 0.15 mg/ kg/hr, 0.3 mg/kg/hr, and 0.6 mg/
Autor:
Masami Kojima, Takashi Koizumi, Kiyoto Hara, Atsushi Matsuzawa, Akane Matsuzawa, Masahiko Uchida, Satoshi Akahane, Toshiki Honma
Publikováno v:
The Journal of Toxicological Sciences. 28:25-34
This study examined a low-molecular-weight factor-Xa inhibitor, KFA-1411 (3-[N-(3-amidinophenyl)-N-[N-[4-[1-(1-iminoethyl)piperidin-4- yl]phenyl]carbamoylmethyl]aminomethyl]phenoxyacetic acid monosulfonate-dihydrate). KFA-1411 selectively inhibited F
Autor:
KOUICHI KAIDOH, YASUHIKO IGAWA, HIROO TAKEDA, YOSHINOBU YAMAZAKI, SATOSHI AKAHANE, HIROSHI MIYATA, YUKIYOSHI AJISAWA, OSAMU NISHIZAWA, KARL-ERIK ANDERSSON
Publikováno v:
The Journal of Urology. :1247-1252
Autor:
Kouichi Kaidoh, Hiroshi Miyata, Satoshi Akahane, Karl-Erik Andersson, Osamu Nishizawa, Yasuhiko Igawa, Yukiyoshi Ajisawa, Hiroo Takeda, Yoshinobu Yamazaki
Publikováno v:
Journal of Urology. 168:1247-1252
Purpose: We evaluated the effects of β-adrenoceptor agonists on detrusor hyperreflexia in cerebral infarcted rats.Materials and Methods: To produce cerebral infarction in Sprague-Dawley rats the left middle cerebral artery was occluded by introducin
Autor:
Kouichi Kaidoh, Yasuhiko Igawa, Hiroshi Miyata, Karl-Erik Andersson, Yoshinobu Yamazaki, Satoshi Akahane, Osamu Nishizawa, Hiroo Takeda, Masuo Akahane
Publikováno v:
Neurourology and Urodynamics. 21:558-565
Aims. To investigate the effects of selective beta(2)- and selective beta(3)-adrenoceptor (AR) agonists on prostaglandin (PG) E-2-induced bladder hyperactivity in conscious free-moving rats. Methods. Female Sprague-Dawley rats were anesthetized for i
Autor:
Nobuyuki Tanaka, Akihito Hirabayashi, Masuo Akahane, Hideyuki Muranaka, Harunobu Mukaiyama, Takehiro Ishikawa, Satoshi Akahane, Tetsuro Tamai
Publikováno v:
Bioorganic & Medicinal Chemistry. 9:3265-3271
In a search for novel analogues of beta(3)-adrenoceptor (AR) agonists relaxing the bladder for treatment of urinary dysfunction, 2-[4-(2-[[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl)phenoxy]-2-methylpropionic acids (1a-e), into w
Autor:
Hideyuki Rasukasasu Azumino Muranaka, Satoshi Akahane, Harunobu Mukaiyama, Hiroshi Miyata, Masuo Akahane, Nobuyuki Tanaka, Akihito Hirabayashi, Tetsuro Tamai
Publikováno v:
Journal of Medicinal Chemistry. 44:1436-1445
With a novel assay using isolated ferret detrusor to estimate beta(3)-adrenoceptor agonistic activity, we found that a series of glycine derivatives of ritodrine, a beta(2)-adrenoceptor agonist, are potent beta(3)-adrenoceptor agonists, with excellen